Describe the nutritional management.
Fluid intake: Ensure appropriate fluid intake and avoid dehydration.
Protein and energy consumption
Mediterranean diet, ↑ fruit and vegetable intake
Protein restriction (e.g., 0.55–0.60 g/kg/day) in patients with CKD category G3–G5
Electrolytes
Sodium restriction (< 2.3 g/day)
Potassium intake adjustment
Phosphorus intake adjustment
Micronutrients: Consider multivitamin supplementation for patients with inadequate dietary vitamin (e.g., vitamin D) intake.
Describe the medication management.
Renally cleared medications: Adjust dosing based on the patient's eGFR.
Potentially nephrotoxic substances
Avoid use (except when the benefits outweigh the risks).
Contrast imaging
The risk of contrast-induced nephropathy is highest in patients with eGFR < 30 mL/min/1.73 m2.
For information on prevention, see “Contrast-induced nephropathy.”
Describe the renal replacement therapy.
Nonoperative (hemodialysis or peritoneal dialysis)
Indications include:
Hemodynamic or metabolic complications that are refractory to medical therapy, e.g.:
Volume overload or hypertension
Metabolic acidosis
Hyperkalemia
Serositis: e.g., uremic pericarditis
Other symptoms of uremia: e.g., signs of encephalopathy
Refractory deterioration in nutritional status
Operative: kidney transplantation
Last changed2 years ago